BENLIDO

This brand name is authorized in Hong Kong SAR China.

Active ingredients

The drug BENLIDO contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII F5UM2KM3W7 - BENZALKONIUM CHLORIDE
 
Read more about Benzalkonium chloride
2
UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
 

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
 
Read more about Lidocaine
3
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
 
Read more about Menthol

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 41724

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈